Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DR26FX3Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,953
Award facts
- Contract value 100% obligated
- $5,952.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,952.66 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price, non-competitive set-aside delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations.
This delivery order represents a routine pharmaceutical supply fulfillment under AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. Trelegy Ellipta is a combination respiratory medication used in treating chronic obstructive pulmonary disease and asthma, reflecting the breadth of specialty and brand-name pharmaceuticals that AmerisourceBergen supplies to support Defense Health Agency and broader federal medical procurement needs. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen routinely fulfills such delivery orders across its extensive therapeutic product portfolio serving military and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FX3Q3?
SPE2DR26FX3Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FX3Q3 worth?
The government has obligated $5,953 on SPE2DR26FX3Q3.
Is contract SPE2DR26FX3Q3 an order under another contract?
Yes. SPE2DR26FX3Q3 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3Q3 competed?
The extent of competition for SPE2DR26FX3Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award